Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 24Prostatic Neoplasms 16Sarcoma 9Carcinoma, Non-Small-Cell Lung 9Lung Neoplasms 5Uterine Cervical Neoplasms 4Endometrial Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Liposarcoma, Myxoid 3Head and Neck Neoplasms 3Glioblastoma 3Triple Negative Breast Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Radiation Injuries 2Pancreatic Neoplasms 2Neurofibrosarcoma 2Neoplasms 2Melanoma 2Lymphatic Metastasis 2Liposarcoma 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Fibrosarcoma 2Carcinoma, Intraductal, Noninfiltrating 2Breast Carcinoma In Situ 2Advanced Refractory Solid Tumors 2Uterine Neoplasms 1Urothelial Cancer 1Urogenital Neoplasms 1

Interventions

sintilimab 2Cisplatin 2Radiation Dose Hypofractionation 1Radiation 1Platinum 1Irinotecan 1Brachytherapy 1Albumin-Bound Paclitaxel 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Locally Advanced Cervical Carcinoma × Radiation Dose Hypofractionation × Clear all
NCT05210270 2023-01-31

HYACINCT

University of Santo Tomas Hospital, Philippines

Phase 1/2 Not yet recruiting
55 enrolled
Gynecologic

Locally Advanced Cervical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡